BIO

Bio Rad Laboratories Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↑ 7/10
  • Momentum↓ 3/10
Bio Rad Laboratories sales and earnings growth
BIO Growth
Good
  • Revenue Y/Y↓ 0.65%
  • EPS Y/Y↑ 142.64%
  • FCF Y/Y↑ 29.34%
Bio Rad Laboratories gross and profit margin trends
BIO Profitability
Good
  • Gross margin ↑ 51.90%
  • EPS margin↑ 29.40%
  • ROIC↓ 10.90%
Bio Rad Laboratories net debt vs free cash flow
BIO Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 2.3
  • Interest coverage↑ 21.3

Bio Rad Laboratories stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗